OnKure Therapeutics (OKUR) awards 110,000 options to Chief Scientific Officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Hartley Dylan reported acquisition or exercise transactions in this Form 4 filing.
OnKure Therapeutics, Inc. reported that Chief Scientific Officer Dylan Hartley received a grant of 110,000 employee stock options to buy Class A Common Stock at $4.07 per share. These options expire on March 31, 2036 and function as equity-based compensation rather than an open-market share purchase.
According to the vesting terms, 1/48th of the options will vest on May 1, 2026 and then monthly thereafter, as long as Hartley continues as a service provider. After this grant, Hartley directly holds 110,000 options covering an equal number of Class A Common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hartley Dylan
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 110,000 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 110,000 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 110,000 options
Exercise price: $4.07 per share
Underlying shares: 110,000 shares
+4 more
7 metrics
Options granted
110,000 options
Employee Stock Option grant to Chief Scientific Officer
Exercise price
$4.07 per share
Strike price for Class A Common Stock under the option
Underlying shares
110,000 shares
Class A Common Stock underlying the employee stock options
Expiration date
March 31, 2036
Option expiration for the 110,000 granted options
Post-grant option holdings
110,000 options
Total derivative holdings following this grant
Initial vesting date
May 1, 2026
First vesting date for 1/48th of the options
Vesting rate
1/48th monthly
Monthly vesting schedule, contingent on continued service
Key Terms
Employee Stock Option, Class A Common Stock, exercise price, vesting, +1 more
5 terms
Employee Stock Option financial
"security_title: "Employee Stock Option (right to buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: "4.0700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"1/48th of the shares subject to the option shall vest on May 1, 2026 and each month thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative financial
""transaction_type": "derivative""
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
FAQ
What insider transaction did OnKure Therapeutics (OKUR) report for Dylan Hartley?
OnKure reported that Chief Scientific Officer Dylan Hartley received a grant of 110,000 employee stock options. These options give him the right to buy Class A Common Stock at $4.07 per share as part of his equity-based compensation package.
What are the key terms of Dylan Hartley’s 110,000 OnKure stock options?
Hartley’s grant covers 110,000 employee stock options with an exercise price of $4.07 per share. The options relate to Class A Common Stock and expire on March 31, 2036, providing a long-dated incentive tied to the company’s future share performance.
How do Dylan Hartley’s OnKure (OKUR) stock options vest over time?
The options vest gradually, with 1/48th of the 110,000 options vesting on May 1, 2026. Additional 1/48th portions vest each month afterward, provided Hartley continues as a service provider, creating a four-year monthly vesting schedule linked to ongoing service.
When do Dylan Hartley’s OnKure stock options expire if unexercised?
The options expire on March 31, 2036 if they are not exercised before that date. This long-term expiration gives Hartley a significant window to potentially exercise the 110,000 options at the $4.07 strike price, subject to vesting and continued service conditions.